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Abstract
Rationale and Objectives—Previous studies have demonstrated a qualitative relationship 
between stone fragility and internal stone morphology. The goal of this study was to quantify 
morphological features from dual-energy CT images and assess their relationship to stone fragility.
Materials and Methods—Thirty-three calcified urinary stones were scanned with micro CT. 
Next, they were placed within torso-shaped water phantoms and scanned with the dual-energy CT 
stone composition protocol in routine use at our institution. Mixed low-and high-energy images 
were used to measure volume, surface roughness, and 12 metrics describing internal morphology 
for each stone. The ratios of low- to high-energy CT numbers were also measured. Subsequent to 
imaging, stone fragility was measured by disintegrating each stone in a controlled ex vivo 
experiment using an ultrasonic lithotripter and recording the time to comminution. A multivariable 
linear regression model was developed to predict time to comminution.
Results—The average stone volume was 300 mm3 (range 134–674 mm3). The average 
comminution time measured ex vivo was 32 s (range 7–115 s). Stone volume, dual-energy CT 
number ratio and surface roughness were found to have the best combined predictive ability to 
estimate comminution time (adjusted R2= 0.58). The predictive ability of mixed dual-energy CT 
images, without use of the dual-energy CT number ratio, to estimate comminution time was 
slightly inferior, with an adjusted R2 of 0.54.
Conclusion—Dual-energy CT number ratios, volume, and morphological metrics may provide a 
method for predicting stone fragility, as measured by time to comminution from ultrasonic 
lithotripsy.
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Introduction
Symptomatic urinary stone disease affects approximately 900,000 persons in the United 
States each year, resulting in an estimated annual medical expenditure of over $1 billion in 
2007 among Medicare beneficiaries alone (1, 2). The prevalence of kidney stones in the 
United States rose by 37% between 1976–1980 and 1988–1994 in both genders (3). Due to 
the effects of global warming, it has been predicted that there could be an increase of 1.6–
2.2 million lifetime cases of urinary stones by 2050 in the United States alone, as kidney 
stones tend to form more frequently in states where dehydration is common (4).
Several surgical options are available for the 10–20% of symptomatic stone formers who fail 
to pass their stones spontaneously (5). Larger, harder kidney stones and those located in the 
lower pole of the kidney tend to be more easily fragmented and removed by percutaneous 
nephrolithotripsy (PCNL), a minimally invasive procedure whereby the stone is accessed 
through a small flank incision which allows direct visualization and intracorporeal ultrasonic 
lithotripsy for stone disruption and removal of fragments (6). Stone fragility, which we 
define as the time to comminution by a given surgical procedure, is affected by the extent of 
the stone burden (i.e., the size and number of stones) as well as its mineral composition (7).
Computed tomography (CT) is the recommended method for non-invasively imaging stones 
in the urinary tract as it can provide accurate sub-millimeter details of the size and location 
of stones anywhere along the urinary system (8, 9). However, differences in x-ray 
attenuation (i.e. CT numbers) from a single peak potential do not accurately discriminate 
between different stone types (10). Dual-energy CT, whereby attenuation properties of tissue 
are measured at two different peak x-ray energies to provide a measure of effective atomic 
number, has proven to be extremely effective at discriminating uric acid (UA) stones from 
non-uric acid (NUA) stones (11, 12) without increasing the radiation dose compared to 
single energy exams (10, 13); it is now the routine outpatient examination for symptomatic 
kidney stone patients at our institution. Limited success in further separating NUA stones 
(calcium oxalate, hydroxyapatite, cysteine and struvite) has also been reported (14, 15).
Among others, Williams et al. reported wide variability in stone fragility (i.e. ease of 
breakage) within groups of stones having the same mineral composition, suggesting that 
variation in stone structure could also play an important role (7). His group also investigated 
possible correlation between CT-visible structures and time to comminution by shock-wave 
lithotripsy (SWL) for a variety of stone types, including brushite (16), cystine (17) and 
calcium oxalate monohydrate (COM) (18). However, the majority of these investigations 
utilized qualitative metrics for assessing the stone morphology on CT; these metrics were 
found to be highly subjective and variable, and were not found to be strong predictors of 
stone fragility.
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In this ex vivo investigation, we propose to add objective measures of internal morphology 
to knowledge of stone volume, composition, and surface morphology to predict stone 
fragility, using metrics derived from routine dose dual-energy CT. Our study aims to do the 
following: a) identify CT-based metrics describing the internal morphology of kidney stones 
that correlate with time to comminution, defined as the time required to completely break 
and remove the stone; and b) assess the predictive ability of using measures obtained from 
routine dose dual-energy CT protocols to estimate stone fragility.
Materials and Methods
Micro-CT imaging
Stones were scanned with a micro-CT system (SkyScan 1172, Bruker, Belgium) to 
determine their composition (19). Briefly, each stone was scanned (dry) using 60 kVp with 
0.4° rotation steps, averaging 4 images for each step. Final isotropic voxels were 20 µm on a 
side. Stone compositions were judged using attenuation values and established composition-
specific characteristics (20). Stone composition was confirmed by infrared spectroscopy. 
IRB protocol approval was not required for this non-patient study. However, biospecimen 
approval was obtained from the institutional biospecimen committee.
Whole-body CT imaging
Subsequent to micro-CT imaging, stones were hydrated for 24 hours in distilled water and 
embedded in gelatin in a 60-well ice-cube tray. The tray was covered with plastic wrap and 
inserted into a 35-cm water phantom and scanned with a clinical, state-of-the art, dual-
source, dual-energy CT scanner (Somatom Force, Siemens Healthcare, Germany) using the 
routine stone composition clinical protocol in use at our institution (90/Sn150 kV, 350/219 
quality reference mAs, ~8 mGy CTDIvol, 0.5 s rotation time, 192 × 0.6 mm collimation). 
The data were reconstructed with the same parameters used by our clinical protocol (300 
mm field of view (FOV), 1 mm slices, 0.8 mm increment, Br44 reconstruction kernel). The 
resulting low- and high-energy images were linearly combined to create a set of mixed 
images. A separate, small FOV (120 mm) reconstruction with smaller pixel size (~0.23 mm) 
was performed to provide a higher spatial resolution image. A side-by-side comparison of 
micro-CT and clinical CT images is shown in Figure 1 for a representative stone.
Texture analysis of stone morphology
Each stone in the mixed images was segmented by our in-house stone analysis software (21) 
using a semi-automated approach to identify the stones and an adaptive threshold method to 
segment it from the surrounding water. Texture analysis requires the computation of the 
distribution of co-occurring values at a given offset in the image. Such distribution is often 
referred to as the co-occurrence matrix and for a 3D image I of size (n,m,o) it is 
mathematically defined as follows:
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The offset (Δx,Δy,Δz) depends on the direction used and the distance d at which the matrix is 
computed. The CT numbers for each stone were discretized in 16 grey levels and 52 
different co-occurrence matrices - 13 directions in the 3 dimensions at 4 different pixel 
distances - were generated from the mixed image for each segmented stone. To calculate the 
Haralick textural features (22) describing internal morphology, the equations in Table 1 were 
applied to each co-occurrence matrix and the average computed for each textural feature. 
Surface roughness (23) and the dual energy CT number ratio (the ratio of the CT number in 
the low-energy image to that at the same voxel in the high-energy image) (12) were 
computed as previously described.
Ex-vivo analysis of stone fragility
To measure the fragility of each stone, we attempted to reproduce ex vivo the environment 
of a percutaneous nephrolithotripsy. Each stone was placed in a vial with water and 
disintegrated using the same ultrasonic lithotripter (Olympus LUS, Melville, NY) used by 
our surgical urologists. The experimental set-up for the ex-vivo analysis of stone fragility is 
shown in Figure 2. The same setting of the lithotripter was used for all stones, regardless of 
their size, as is done in our clinical practice. We recorded the time required to break and 
completely remove each stone from its vial and used this time to comminution as the figure 
of merit to quantify stone fragility.
Statistical analysis
Associations between stone morphology characteristics and comminution time were 
assessed using both simple and multivariable linear regression. Comminution time was 
evaluated using a natural log transformation for all analyses to account for its skewed 
distribution. When performing multivariable analyses, models were first adjusted for volume 
(i.e. two variable models), as this variable was considered a priori to be a critical predictor of 
stone comminution time. Best subset selection methods were used for the remaining 
predictors, based on the statistical significance of all predictors in the model (p<0.05 for all), 
the variance inflation factors (VIF) of the coefficients to detect the presence of multi-
collinearity (VIF<3 for all) and the adjusted R2 cutoff (24). In order to extend the 
applicability of the model to single energy CT, we used an identical modeling process to 
investigate the subset of multivariable models that did not require dual energy. Model size 
was restricted to three variables due to limited sample size. The best model was then used to 
predict the comminution time for each stone. All statistical analysis was performed using the 
R statistical software (25).
Results
Our study cohort consisted of 33 stones: primarily pure calcium oxalate monohydrate 
(COM) stones (N=7), mixed COM and apatite (APA) stones (N=2), and mixed calcium 
oxalate (CaOx, which contained both COM and calcium oxalate dihydrate) and APA stones 
(N=24). The average volume of the stones was 300 mm3 (range 134–674 mm3). The average 
comminution time measured ex vivo was 32 s (range 7–115 s). The correlation matrix for 
the investigated variables is shown in Supplemental Figure 1.
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Univariate and volume-adjusted models of stone fragility
We report three kinds of models: univariate (1 variable), volume-adjusted (volume + 1 
variable), and best multi-variable model to fit our stone samples (volume + 2 variables). The 
univariate regression models using a single predictor are shown in Table 2. Despite 
limitations in spatial resolution associated with clinical CT data, several internal and surface 
morphological features were found to be significantly associated with time to comminution. 
In particular, homogeneity, surface roughness and CT number at the higher tube potential 
selection (HU high) yielded a higher adjusted R2 than volume.
Table 2 also reports all volume-adjusted models. Three volume-adjusted models met our 
requirements for statistical significance and acceptable VIF; these models are bolded in 
Table 2 and are referred to as the best subset. The best volume-adjusted model incorporated 
CT number ratio because it demonstrated the highest adjusted R-squared (R2adj = 0.52). The 
next best volume-adjusted model in best subset of models adjusted for volume incorporated 
max probability (R2adj = 0.42). We note that this model does not include variables that 
require a dual-energy scan, such as the CT number ratio. Assuming the equivalence of mixed 
dual-energy CT images to single-energy CT images, this model could be considered 
representative of single-energy CT scans. It was also noted that the volume-adjusted model 
using surface roughness had a high R-squared and statistically significant p-value for surface 
roughness (p = 0.05), but the insignificance of volume (p = 0.53) and high VIF of 7.3 
disqualified this model from our best subset.
Best multivariable “single-energy” CT models of stone fragility
Using the mixed dual-energy images as surrogates for single-energy images, volume, max 
probability, and sum mean were the best predictors in the multivariable, “single-energy” 
model (i.e. models without the use of CT number ratio, R2adj = 0.54) (Table 3). The two 
bolded models (using volume, max probability and surface roughness and volume, max 
probability and variance) were also included in our best subset. While three other variables 
(cluster shade, homogeneity, and surface roughness), were statistically significant when 
individually combined to volume and max probability, the p-value for volume was greater 
than 0.05 for these models. Additionally, these models had 2 or more VIFs greater than 3.
Best multivariable dual-energy CT models of stone fragility
The best dual-energy CT model included the metrics volume, CT number ratio and peak 
curvature (R2adj = 0.58), while the best subset additionally included the models using 
metrics HU Low and HU High, as shown in Table 4.
Discussion
The best multivariable model for a mixed images, which did not take into account energy-
specific information, included the metrics stone volume, max probability and sum mean, and 
accounted for 54% of the variability in stone comminution time (Table 3). The best 
multivariable model using dual energy metrics included the variables volume, dual-energy 
CT number ratio and surface roughness, and explained 58% of the variability in 
comminution time (Table 4). The limited additional contribution of dual-energy metrics is 
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likely due to the similar mineral composition of the stones in our population, which was 
intentional in our study design as the vast majority of stones that are removed through PCNL 
consist of CaOx with different degrees of apatite. Acknowledging the potential importance 
of stone composition, we used a combination of infrared spectroscopy and microCT to have 
the best confidence on the minerals contained in our stone specimens (26).
From the scatter plot of the predicted comminution time shown in Figure 3, we see that the 
distribution of the errors is not even, with 2 of the specimens in particular appearing to be 
outlying values. This could be due to the fact that important predictor variables have a non-
linear relationship with comminution time or have been omitted from the model; however, 
due to the limited sample size for this study, we are unable to reliably fit more complex 
models to our data at present.
To our knowledge, our study is the first attempt at introducing quantitative metrics 
describing stone morphology to predict stone fragility. If validated in vivo, the predictive 
models for stone fragility developed in this study would provide valuable information for 
both the urologic surgeon and the patient to better evaluate treatment options. For example, 
larger, more fragile stones may be amenable to ureteroscopic stone removal or SWL, which 
are both less invasive procedures; however, smaller, denser stones may be more efficiently 
and completely cleared with PCNL, justifying this more invasive procedure. This additional 
information would be available to the urologist without additional radiation dose to the 
patient, and could be made readily available, as the computational burden to generate the 
texture features is minimal, taking only a few seconds on a regular computer. There are 
additional clinical implications of a quantitative fragility model. Larger stone size - which is 
accounted for in all of our models – increases the rate of complications during PCNL (27). 
Furthermore, the duration of surgical removal of kidney stones has been shown to be a 
significant risk factor for the development of postoperative fever (28).
This study has several limitations. The cohort of stones was fairly small and consisted 
mostly of calcium oxalate stones mixed with different degrees of apatite. As mentioned 
earlier, this selection of stone types was intentional in this proof of feasibility study, since we 
did not want differences in stone composition creating additional noise in the data. Several 
studies in the literature have showed how calcium oxalate is the most prevalent mineral in 
kidney stones treated clinically by PCNL, with 60–70% of all stones treated consisting 
predominantly of CaOx (29, 30). Since dual-energy metrics mainly reflect differences in 
mineral composition, it is not surprising that they provided little additional predictive ability 
in the fragility models developed from our relatively homogeneous stone population. In 
future studies, our cohort will be expanded to include stones of different minerals 
compositions and the fragility models derived from dual energy data are expected to more 
significantly outperform the ones derived from single energy CT. Moreover, the ex vivo 
analysis of stone fragility precluded inclusion of factors such as the location of the stone in 
the patient, which can have a major effect on both comminution time and overall surgery 
outcome. Finally, several of the stones that were analyzed were extracted from the same 
patients. However, since our fragility models did not make use of any patient-specific 
characteristics (e.g. urine analysis), we believe that the origin of the stone does not 
appreciably affect the results.
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Conclusions
These preliminary results provide evidence that the routine single and dual energy scan renal 
stone protocols used in our clinical practice can also provide morphology metrics that can 
help serve as predictors of stone comminution time. A combination of volumetric, 
morphological and dual energy characteristics was shown to predict the comminution time 
with reasonable accuracy (adjusted R2 = 58%). Without the dual energy metrics, the best 
model accounted for 54% of the variability in stone comminution time. Currently, a larger 
study with different stone minerals is ongoing, with the goal of developing a comprehensive 
model of stone fragility that uses in vivo information of stone size composition and 
morphology to accurately predict its fragility during clinical PCNL.
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Figure 1. 
Qualitative comparison of CT images of a representative stone. Left, reference micro-CT 
scan used to determine stone composition (CaOx with apatite). Middle: Small field-of-view 
reconstruction from the routine stone composition protocol at our institution. Right: full 
field-of-view, clinical CT reconstruction from the same acquired data.
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Figure 2. 
our ex-vivo experiment to measure time to comminution for each stone
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Figure 3. 
Plot comparing observed vs predicted comminution time based on the multivariable model 
with predictors volume, CT ratio and shape index. The size of each point is proportional to 
that stone’s volume (mm3)
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Table 1
Haralick features describing stone internal morphology (1–12) and features describing stone surface (13–15) 
cooc = co-occurrence matrix 22,23,30.
Variable Formula Interpretation
1. Energy Uniformity of theImage
2. Entropy Randomness of theimage
3. Correlation
Local gray level
linear dependency
of the image
4. Contrast
Measure of local
variations in the
image
5. Homogeneity Local homogeneity
of the image
6. Variance Gray-level variability
of the pixel pairs
7. Sum Mean N.A.
8. Inertia N.A.
9. Cluster Shade Skewness of theimage.
10. Cluster
Tendency
Another measure of
asymmetry of the
image
11. Max probability max(cooc) N.A.
12. Inverse variance Local homogeneity
of the image
13. Shape Index FWHM of histogram of vertex curvatures
Overall surface
morphology of a
stone
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